World Investment Advisors’s AstraZeneca AZN Stock Holding History

World Investment Advisors’s Portfolio AZN Stock Details AZN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.02M	Sell	10,283 -3,496	-25%	-$658K	0.03%	472
2026 Q1	$2.7M	Buy	13,779 +230	+2%	+$44.3K	0.04%	403
2025 Q4	$2.49M	Buy	13,549 +7,063	+109%	+$1.24M	0.04%	416
2025 Q3	$995K	Buy	6,486 +1,110	+21%	+$168K	0.02%	566
2025 Q2	$751K	Buy	5,376 +1,422	+36%	+$199K	0.02%	599
2025 Q1	$581K	Sell	3,954 -328	-8%	-$47.5K	0.02%	650
2024 Q4	$561K	Buy	4,282 +148	+4%	+$20.7K	0.02%	642
2024 Q3	$644K	Buy	4,134 +2,215	+115%	+$358K	0.02%	520
2024 Q2	$299K	Buy	+1,919	New	+$289K	0.02%	500

Other funds holding AZN

Evelyn Partners London $46.9B AUM

Investor AB Stockholm, Sweden $14.4B AUM 4.07% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Legal & General Group London, United Kingdom $480B AUM 42.84% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

World Investment Advisors's AZN Position: Q2 2026 in Review

World Investment Advisors reduced its AstraZeneca (AZN) stake by 25% in Q2 2026, selling an estimated $658K and leaving 10,283 shares worth $2.02M. The position accounts for 0.03% of the portfolio, ranked #472.

World Investment Advisors first reported a position in AZN in Q2 2024 and has held it in 9 quarters since. The position peaked at $2.7M in Q1 2026. 1,495 funds tracked by Wall St. Rank hold AZN as of Q2 2026.

World Investment Advisors held 10,283 shares of AstraZeneca worth $2.02M as of Q2 2026.
World Investment Advisors sold 3,496 AstraZeneca shares in Q2 2026, an estimated $658K.
AstraZeneca made up 0.03% of World Investment Advisors's portfolio in Q2 2026, its #472 holding.
World Investment Advisors first reported a position in AstraZeneca in Q2 2024 and has held it in 9 quarters since.
World Investment Advisors's AstraZeneca position peaked at $2.7M in Q1 2026.
1,495 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2026.

Based on World Investment Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.